CAS MEDICAL SYSTEMS, INC. (NASDAQ:CASM) Files An 8-K Submission of Matters to a Vote of Security Holders

CAS MEDICAL SYSTEMS, INC. (NASDAQ:CASM) Files An 8-K Submission of Matters to a Vote of Security Holders

Story continues below

Item 5.07 Submission of Matters to a Vote of Security Holders.


At the annual meeting of stockholders of CAS Medical Systems,
Inc. (the “Company”) held on June 21, 2017, three proposals
were voted upon and approved by the Company’s stockholders. A
brief description of each proposal voted upon at the annual
meeting and the number of votes cast for, against, and withheld,
as well as the number of abstentions and broker non-votes, where
applicable, are set forth below.

(1) Election of seven members of the Board of Directors, each for
a term of one year:


Nominee

For

Withheld

Broker
Non-Votes


Alan W. Milinazzo

18,946,953

481,010

10,775,664


Paul A. Molloy

18,986,517

441,446

10,775,664


Thomas M. Patton

18,985,122

442,841

10,775,664


Gregory P. Rainey

18,978,492

449,471

10,775,664


James E. Thomas

18,976,617

451,346

10,775,664


Kathleen A. Tune

18,885,277

542,686

10,775,664


Kenneth R. Weisshaar

18,986,492

441,471

10,775,664

(2) Advisory approval of the compensation of the Company’s named
executive officers:

For

Against

Abstain

Broker Non-Votes

18,903,847

466,424

57,692

10,775,664

(3) Ratification of the appointment of CohnReznick LLP as auditor
for the Company for the fiscal year ending December 31, 2017:

For

Against

Abstain

29,886,485

257,250

59,892


About CAS MEDICAL SYSTEMS, INC. (NASDAQ:CASM)

CAS Medical Systems, Inc. is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It also sells various legacy products called Traditional Monitoring, which includes non-invasive blood pressure measurement technologies, neonatal medical disposables and service sales. It operates through two categories of sales: Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories, and Traditional Monitoring, which includes sales of its legacy products comprising the original equipment manufacturer (OEM) sales of its non-invasive blood pressure technology (MAXNIBP and MAXIQ), and monitor service and repair. The FORE-SIGHT Tissue Oximeter technology provides clinicians a non-invasive, quantitative measurement of oxygenation in cerebral tissue.

An ad to help with our costs